Labcorp (LH)
(Delayed Data from NYSE)
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
by Trina Mukherjee
Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.
LabCorp (LH) Q3 Earnings Beat Estimates, Margins Expand
by Zacks Equity Research
LabCorp (LH) Diagnostics business in Q3 grows significantly on organic volume improvements as a result of growing demand for COVID-19 testing.
LabCorp (LH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
LabCorp (LH) delivered earnings and revenue surprises of 58.98% and 4.70%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
LabCorp (LH) Extends Pact With Swedish for Coronavirus Lab Service
by Zacks Equity Research
Under the extended alliance, LabCorp (LH) expects to expand its COVID-19 test capacity in the Seattle area.
LabCorp (LH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed the most recent trading day at $203.16, moving -1% from the previous trading session.
LabCorp (LH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Higher Testing Volume to Aid LabCorp's (LH) Q3 Earnings
by Zacks Equity Research
In Q3, LabCorp (LH) significantly expands accessibility of PCR testing to reach underserved communities.
Will LabCorp (LH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LabCorp (LH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed the most recent trading day at $195.76, moving +0.77% from the previous trading session.
LabCorp Heat Extraction COVID-19 Test Method Gets FDA's EUA
by Urmimala Biswas
According to LabCorp (LH), this process traps viral particles, eliminating the need for RNA extraction reagents.
LabCorp (LH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed at $187.99 in the latest trading session, marking a +0.58% move from the prior day.
Quest Diagnostics' 3-in-1 Coronavirus Test Launch Well Timed
by Zacks Equity Research
According to Quest Diagnostics (DGX), under such situation, laboratory testing that can reliably identify the virus causing disease will be critical to mobilize effective patient care.
LabCorp Coronavirus Test Sales Aid Growth Amid Volume Woes
by Zacks Equity Research
There has been a steady recovery in the Base Business of LabCorp (LH).
3 Beaten-Down MedTech Stocks to Grab Amid Market Meltdown
by Sriparna Ghosal
These cheap MedTech stocks are currently flourishing on the back of a number of positive developments.
3 Great MedTech Stocks to Pick Amid the Coronavirus Crisis
by Sriparna Ghosal
Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.
LabCorp Boosts Oncology Offerings With Resolution ctDx Launch
by Zacks Equity Research
This development comes on the heels of LabCorp's (LH) commercial partnership with non-invasive liquid biopsy platform developer, Resolution Bioscience.
Bull Of The Day: Quest Diagnostics (DGX)
by Daniel Laboe
Quest Diagnostics (DGX) has been one of the coronavirus heroes, having performed 14.4 million COVID-19 diagnostics tests and 3.6 million antibody tests
LabCorp (LH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed the most recent trading day at $184.33, moving +0.51% from the previous trading session.
Is Another Great Depression Imminent or Is it Just a Myth?
by Urmimala Biswas
Asian countries have already shown clear signs of major economic recession.
Thermo Fisher Expands Lab Plastic Making for Coronavirus Support
by Zacks Equity Research
Thermo Fisher (TMO) consumables already support critical COVID-19 work and include sample collection vials and lab essentials.
LabCorp (LH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, LabCorp (LH) closed at $183.13, marking a +0.91% move from the previous day.
LabCorp (LH) Stock Moves -1.24%: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed at $174.72 in the latest trading session, marking a -1.24% move from the prior day.
LabCorp (LH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
LabCorp (LH) closed at $177.41 in the latest trading session, marking a +1.81% move from the prior day.
Why Is LabCorp (LH) Down 7.9% Since Last Earnings Report?
by Zacks Equity Research
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp (LH) Banks on Covance Amid Testing Volume Pressure
by Zacks Equity Research
LabCorp's (LH) COVID-19 related research too has been progressing well.